Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A bacterial selection for the directed evolution of pyruvate aldolases.
A Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study.
Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti-c-Met Antibody, in Patients with Advanced Solid Tumors.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A bacterial selection for the directed evolution of pyruvate aldolases.
A bacterial selection for the directed evolution of pyruvate aldolases. Bioorg Med Chem. 2004 Aug 01; 12(15):4067-74.
View in:
PubMed
subject areas
Aldehyde-Lyases
Directed Molecular Evolution
Escherichia coli
Models, Molecular
Molecular Structure
Mutation
Protein Structure, Tertiary
Pyruvate Kinase
Pyruvates
Substrate Specificity
authors with profiles
Luka Pocivavsek